Abstract
This article provides an example of a smooth and successful withdrawal of long-term and unjustified use of a diuretic (torasemide) in patients with type 2 diabetes mellitus with comorbid obesity by prescribing sodium-glucose cotransporter type 2 inhibitor (dapagliflozin).
Keywords: dapagliflozin, type 2 diabetes mellitus, obesity, torasemide.
Keywords: dapagliflozin, type 2 diabetes mellitus, obesity, torasemide.
For citation:Gorban V.V., Gerasimenko I.A. The experience of successful use of dapagliflozin to manage adverse effects due to uncontrolled and long-term use of torasemide in a patient with type 2 diabetes mellitus with comorbid obesity. A clinical example. Clinical review for general practice. 2024; 5 (4): 6–8 (In Russ.). DOI: 10.47407/kr2024.5.4.00413
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
